References
] , “All-Cause Mortality for Life Insurance Applicants with a Family History of Coronary Artery Disease Before 60.”, J Insur Med, vol. 47, no. 3, pp. 159-171, 2018.
, “Breast cancer-related deaths according to grade in ductal carcinoma in situ: A Dutch population-based study on patients diagnosed between 1999 and 2012.”, Eur J Cancer, vol. 101, pp. 134-142, 2018.
, “Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.”, Int J Cancer, vol. 142, no. 1, pp. 165-175, 2018.
, “Does an Absent Left Main Lead to a Main Event?”, J Insur Med, vol. 47, no. 3, pp. 184-186, 2018.
, “An Irregular Rhythm with Missing P Waves.”, J Insur Med, vol. 47, no. 3, pp. 187-190, 2018.
, “A Man (or a Woman) is Known by the Company He/She Keeps.”, J Insur Med, vol. 47, no. 3, pp. 141-142, 2018.
, “Nationwide population-based study of trends and regional variation in breast-conserving treatment for breast cancer.”, Br J Surg, vol. 105, no. 13, pp. 1768-1777, 2018.
, “Neck Mass in a Five-year-old Afghan Child.”, J Insur Med, vol. 47, no. 3, pp. 191-193, 2018.
, “Takotsubo Syndrome - Case Review.”, J Insur Med, vol. 47, no. 3, pp. 176-183, 2018.
, “Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.”, Eur J Cancer, vol. 102, pp. 82-94, 2018.
, “Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Year”, J Insur Med, vol. 47, no. 3, pp. 143-158, 2018.
, “Validation and update of a lymph node metastasis prediction model for breast cancer.”, Eur J Surg Oncol, vol. 44, no. 5, pp. 700-707, 2018.
, “The Vanishing Art of Medical Underwriting.”, J Insur Med, vol. 47, no. 3, pp. 172-175, 2018.
, “All-Cause Mortality for Life Insurance Applicants with a History of Prostate Cancer.”, J Insur Med, vol. 47, no. 2, pp. 95-106, 2017.
, “All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer.”, J Insur Med, vol. 47, no. 1, pp. 6-22, 2017.
, “Breast Microcalcifications and Their Implications for Risk Assessment. A Brief Review.”, J Insur Med, vol. 47, no. 1, pp. 40-42, 2017.
, “The Cancer Mortality Risk Project - Cancer Mortality Risks by Anatomic Site: Part 1 - Introductory Overview; Part II - Carcinoma of the Colon: 20-Year Mortality Follow-up Derived from 1973-2013 (NCI) SEER*Stat Survival Database.”, J Insur Med, vol. 47, no. 2, pp. 65-94, 2017.
, “Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.”, J Med Econ, vol. 20, no. 10, pp. 1018-1023, 2017.
, “Employment-related difficulties and distressed living condition in patients with hepatitis B virus: A qualitative and quantitative study.”, BMC Public Health, vol. 17, no. 1, p. 568, 2017.
, “A "Full Monty" Issue of the Journal.”, J Insur Med, vol. 47, no. 1, pp. 3-5, 2017.
, “Genetic Insurance Discrimination in Sudden Arrhythmia Death Syndromes: Empirical Evidence From a Cross-Sectional Survey in North America.”, Circ Cardiovasc Genet, vol. 10, no. 1, 2017.
, “Genetics and Insurance in Australia: Concerns around a Self-Regulated Industry.”, Public Health Genomics, vol. 20, no. 4, pp. 247-256, 2017.
, “Infarction or Pseudo-infarction?”, J Insur Med, vol. 47, no. 1, pp. 50-54, 2017.
, “The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.”, Br J Cancer, vol. 117, no. 2, pp. 179-188, 2017.
, “Kikuchi Disease.”, J Insur Med, vol. 47, no. 1, pp. 55-57, 2017.
Pages
